Healthpeak Properties (DOC) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
30 Apr, 2026Executive summary
Reported Q1 2025 net income of $0.06 per share, Nareit FFO of $0.45, FFO as Adjusted of $0.46, and AFFO of $0.43 per share, with 7.0% year-over-year same-store cash NOI growth.
Completed integration of Physicians Realty Trust, expanding outpatient medical footprint and accelerating transformation.
Executed 1.2 million sq. ft. of new and renewal leases in Q1, with strong retention and positive cash releasing spreads in both outpatient medical and lab segments.
Promoted Kelvin Moses to CFO, emphasizing strategic and operational focus and internal leadership succession.
Maintains strong investment-grade balance sheet and ample liquidity.
Financial highlights
Q1 2025 net income attributable to common shares was $42.4 million, up from $6.5 million in Q1 2024.
Nareit FFO rose to $323.3 million ($0.45/share), FFO as Adjusted to $329.7 million ($0.46/share), and AFFO to $306.4 million ($0.43/share), all up year-over-year.
Total revenues for Q1 2025 were $702.9 million, up from $606.6 million in Q1 2024.
Same-store cash NOI grew 7.0% year-over-year, with outpatient medical up 5.0%, lab up 7.7%, and CCRC up 15.9%.
Senior housing occupancy at 86%, with 16% same-store growth.
Outlook and guidance
Reaffirmed full-year 2025 guidance: diluted EPS of $0.30–$0.36, Nareit FFO and FFO as Adjusted per share of $1.81–$1.87.
Expects total same-store cash NOI growth of 3.0%–4.0% for 2025.
$500 million investment guidance for the year, now including stock buybacks for flexibility.
Management expects cash flows, available cash, and financing activities to be adequate for operating expenses, debt service, and distributions for the next 12 months and beyond.
Latest events from Healthpeak Properties
- Earnings and guidance rose on Janus Living IPO, senior housing gains, and major JV proceeds.DOC
Q2 2026 - All director nominees and proposals passed with a 91% quorum and no shareholder questions.DOC
AGM 2026 - 2026 guidance raised after Janus Living IPO, strong leasing, and robust capital actions.DOC
Q1 2026 - Key votes include board elections, executive pay approval, and auditor ratification for 2026.DOC
Proxy Filing - 2025 saw strong results, board refreshment, and enhanced ESG, with key votes on directors, pay, and auditor.DOC
Proxy Filing - Janus Living IPO and operational efficiencies position Healthpeak for growth in core healthcare real estate.DOC
Citi’s Miami Global Property CEO Conference 2026 - Janus Living IPO, $600M biotech campus acquisition, and $1B capital recycling drive growth.DOC
Investor presentation - 2026 guidance anticipates lab headwinds, but growth is driven by Outpatient and Senior Housing.DOC
Q4 2025 - Q2 2025 saw strong NOI growth, higher AFFO/FFO, and robust liquidity.DOC
Q2 2025